Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA's Sunscreen Progress Gets Dim Review From Congressional Appropriators

Executive Summary

House and Senate appropriators' take note that US FDA has not approved an additional OTC sunscreen ingredient since the 2014 passage of the Sunscreen Innovation Act.

Advertisement

Related Content

Toxicity Testing For Topical Drugs, Sunscreens Included, On Tap In US FDA Workshop
House Passes US OTC Monograph Reform And Committee Clears HSA Change
FDA Could Stick With Current Advice On NDI Notifications, Old Ingredient Evidence
Spray Sunscreens Stay In FDA Enforcement Discretion Shade
Spray Sunscreens Stay In FDA Enforcement Discretion Shade
FDA’s MUsT Draft Guidance Extends Challenge To Wider OTC Drug Industry
Gottlieb Showing Capitol Hill Skills With Funding Success
FSMA Re-inspection Fees MIA As Waiver Guidance Remains AWOL

Topics

Advertisement
UsernamePublicRestriction

Register

PS123641

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel